Skip to content

Clinical trials

Phase 2 Anemia, Refractory, with Excess of Blasts trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Phase: Phase 2 Clear all

134 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20019
20024
20038
20047
20056
20066
20076
20083
20097
20107
20112
20125
20132
20143
20152
20161
20172
20184
20191
20203
20212
20222
20232
20241
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed80
Terminated19
Recruiting18
Active, not recruiting6
Unknown status6
Withdrawn4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center14
National Cancer Institute (NCI)9
Masonic Cancer Center, University of Minnesota7
Memorial Sloan Kettering Cancer Center6
M.D. Anderson Cancer Center5
Case Comprehensive Cancer Center4
European Organisation for Research and Treatment of Cancer - EORTC4
National Heart, Lung, and Blood Institute (NHLBI)4
Roswell Park Cancer Institute4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts134
Myelodysplastic Syndromes86
Leukemia, Myeloid, Acute71
Leukemia66
Leukemia, Myelomonocytic, Chronic61
Precursor Cell Lymphoblastic Leukemia-Lymphoma51
Anemia, Refractory47
Myeloproliferative Disorders37
Congenital Abnormalities30
Leukemia, Myeloid, Accelerated Phase29

Trials

Showing 26 to 50 of 134. Each trial links to its page on Pharma Observatory.

34 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.